Rate My Professor Michelle Hartley-McAndrew

Michelle E. Hartley-McAndrew, MD, is Clinical Associate Professor in the Department of Pediatrics at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences, a position she has held since 2019. She currently serves as Chief of the Division of Developmental Pediatrics and Rehabilitation since 2023, Attending Physician in Developmental Pediatrics and Rehabilitation at Oishei Children’s Hospital since 2015, Medical Director of the Children’s Guild Foundation Autism Spectrum Disorder Center at Oishei Children’s Outpatient Center since 2010, and Clinical Assistant Professor of Neurology since 2008. From 2015 to 2019, she was Clinical Assistant Professor of Pediatrics, and from 2008 to 2010, she acted as an Independent Reviewer for the National Vaccine Injury Compensation Program.

Dr. Hartley-McAndrew earned her MD in Medicine from University College Dublin in 2001 and a BA in Pre-Med, Italian Culture and Language from Wellesley College, Cum Laude, in 1996. She completed her postgraduate training at the University at Buffalo: Pediatrics internship in 2002, Pediatrics residency in 2004, Child Neurology residency in 2007, and Neurophysiology fellowship in 2008. Board-certified in Pediatrics by the American Board of Pediatrics and in Psychiatry and Neurology with special qualification in Child Neurology by the American Board of Psychiatry and Neurology, her clinical practice centers on autism spectrum disorders, children with related developmental disabilities, early childhood development, and evaluation and treatment of seizures in children with autism spectrum disorder and related developmental disabilities. Her research specializations encompass autism spectrum disorders, neurodevelopment, early childhood development and autism spectrum disorders, neonatal hypoxic-ischemic encephalopathy, and neurodevelopmental outcomes of preterm infants. Key publications include the book Medical and Educational Needs for Autism (Elsevier, 2024, with Kathy Ralabate Doody); "Whole-Body Hypothermia for Neonatal Encephalopathy in Preterm Infants 33 to 35 Weeks' Gestation: A Randomized Clinical Trial" (JAMA Pediatrics, 2025); "Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula: A Randomized Clinical Trial" (JAMA, 2024); "Effect of Depth and Duration of Cooling on Death or Disability at Age 18 Months Among Neonates With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial" (JAMA, 2017); and "Rates of Autism Spectrum Disorder Diagnosis Under the DSM-5 Criteria Compared to DSM-IV-TR Criteria in a Hospital-Based Clinic" (Pediatric Neurology, 2016).